Farmashop
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Farmashop - overview
Established
1998
Location
Montevideo, -, Uruguay
Primary Industry
Retail
About
Coboe S. A. operates under name Farmacia Farmashop, a company that delivers a wide array of pharmaceutical and wellness products, focusing on health and beauty solutions for consumers throughout Uruguay. Founded in 1998 and headquartered in Montevideo, Uruguay, Coboe S.
A. specializes in retailing health and wellness products. The company was acquired by Linzor Capital Partners in January 2013 and moved its initial fund to a continuation fund in June 2025, enhancing its operational capacity and market reach. The current CEO is Martin Sorrosal.
Farmacia Farmashop specializes in a comprehensive range of pharmaceutical and wellness products, catering primarily to individual consumers seeking health and beauty solutions. The company’s core offerings encompass medications, personal care items, cosmetics, skincare, and wellness products, including both prescription and over-the-counter options. Farmashop operates within several geographical markets, providing its services through both online sales and physical retail locations across the region. Farmacia Farmashop generated revenue of USD 228.
68 mn in 2023, with an EBITDA of USD 31. 09 mn for the same year. Revenue is primarily derived from direct sales to consumers through e-commerce and in-store purchases, supported by loyalty programs and seasonal promotions. As part of its future growth strategy, Coboe S.
A. is focused on expanding its product line to include new wellness solutions and personal care items, with plans for launches in the next fiscal year. The company aims to penetrate additional markets in South America to broaden its consumer base. Recent funding from Linzor Capital Partners will support these initiatives, ensuring that the company can effectively scale operations and enhance its market presence.
Current Investors
Linzor Capital Partners
Primary Industry
Retail
Sub Industries
Drug Stores/Convenience Stores
Website
www.farmashop.com.uy
Verticals
E-commerce
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Farmashop - timeline of key events

Farmashop - financials
| Fiscal Year Ended | Sep 30, 2018 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | Sep 30, 2023 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 4,800,763,361 | 5,373,054,160 | 5,889,213,523 | - | - | - |
| % Revenue Growth (YoY) | - | 11.9% | 9.6% | - | - | - |
| EBITDA (USD) | 500,769,559 | 602,131,758 | 777,073,229 | - | - | - |
| Operating Income (USD) | 372,531,163 | 467,910,668 | 507,825,718 | - | - | - |
| Operating Margin | 7.8% | 8.7% | 8.6% | - | - | - |
| % EBITDA Margin | 10.4% | 11.2% | 13.2% | - | - | - |
| NET Income (USD) | 166,798,329 | 253,120,637 | 202,884,515 | - | - | - |
| % Net Margin | 3.5% | 4.7% | 3.4% | - | - | - |
Farmashop - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Farmashop | - | ||||||||
| Buyout | Completed | Farmashop | - |
Displaying 1 - 2 of 2
Farmashop - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.